Advinus optimistic about diabetes drug candidate

05/4/2009 | Business Standard (India)

Advinus Therapeutics plans to begin in June clinical trials of an experimental molecule that could be categorized under a new class of diabetes drugs, CEO Rashmi Barbhaiya said. The compound is being developed in Advinus' facility in Pune, India, which handles seven to eight drug-discovery programs.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC